RxDoctor Payments Data

Michael Stott

Podiatrist · Bel Air, MDNPI 1235581281

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (57.4%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Supreme Orthopedic Systems, LLC at 58.1% of the total.

$6,830in general payments, 2019–2025

Across 61 payments — averaging $111.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Supreme Orthopedic Systems, LLC$4K
  • Treace Medical Concepts, Inc.$2K
  • Smith+Nephew$228
  • Pacira Pharmaceuticals Incorporated$112
  • Integra Lifesciences Corporation$111
  • Amgen$93
  • plus $443 from 18 others

What the payments were for

  • Travel & lodging$1,10116%
  • Food & beverage$1,80526%
  • Education$3,92457%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,830 in reported general payments places this provider in the 85th percentile of 183 podiatrist providers in Maryland.

See all podiatrist providers in Maryland

Medicare billing

Part B allowed, 2024
$233,511
Medicare patients
664
Services billed
3,316

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ammonium Lactate68$1,739
Ketoconazole65$1,680
Ciclopirox30$974
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav35$290
Gabapentin15$243
Meloxicam30$165
Methylprednisolone24$162
Oxycodone Hcl37$117
Ibuprofen18$110
Cephalexin15$96
Triamcinolone Acetonide13$67
Tramadol Hcl11$49

Paid to pharmacies, not to this prescriber.

Other podiatrist in Bel Air

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →